0001213900-21-058209.txt : 20211110
0001213900-21-058209.hdr.sgml : 20211110
20211110172429
ACCESSION NUMBER: 0001213900-21-058209
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211101
FILED AS OF DATE: 20211110
DATE AS OF CHANGE: 20211110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: David Matthew T
CENTRAL INDEX KEY: 0001811612
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34673
FILM NUMBER: 211397941
MAIL ADDRESS:
STREET 1: 400 CONNELL DRIVE
STREET 2: SUITE 5000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CorMedix Inc.
CENTRAL INDEX KEY: 0001410098
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-9500
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
doc4.xml
PRIMARY DOCUMENT
X0306
4
2021-11-01
false
0001410098
CorMedix Inc.
CRMD
0001811612
David Matthew T
C/O CORMEDIX INC.
300 CONNELL DRIVE, SUITE 4200
BERKELEY HEIGHTS
NJ
07922
false
true
false
false
Interim CEO and CFO
Common Stock
1150.0000
D
Stock Option (Right to Buy Common Stock)
5.5600
2021-11-01
4
A
false
125000.0000
0.0000
A
2031-11-01
Common Stock
125000.0000
125000.0000
D
Stock Option (Right to Buy Common Stock)
8.3200
2031-01-11
Common Stock
80000.0000
80000.0000
D
Stock Option (Right to Buy Common Stock)
5.6300
2030-05-11
Common Stock
125000.0000
125000.0000
D
Stock Option (Right to Buy Common Stock)
4.0800
2030-05-11
Common Stock
125000.0000
125000.0000
D
These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.
/s/ Matthew T. David
2021-11-10